Cline Christopher R.
SEC insider (Form 3/4/5 filer). CIK 0001943192. CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc. (TVTX). 33 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in SAN DIEGO, CA.
Companies Cline Christopher R. has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Officer, CHIEF FINANCIAL OFFICER
Cline Christopher R.
CIK: 0001943192
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect27.5K shares at avg. $62.00$1.7M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect1.9K shares at avg. $63.69$121K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect400 shares at avg. $65.31$26K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect20.7K shares at avg. $62.61$1.3M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect20K shares at avg. $17.44$349K - Sep 2, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect642 shares at avg. $66.37$43K - May 6, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect310 shares at avg. $43.95$14K - May 5, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect2.2K shares at avg. $46.65$102K - May 4, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect4.3K shares- - May 4, 2026TVTX
Travere Therapeutics, Inc.
AwardDirectPerformance-based restricted stock units
8.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 27,473 | $62.00 | $1,703,241 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 1,900 | $63.69 | $121,004 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 400 | $65.31 | $26,124 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 20,735 | $62.61 | $1,298,175 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 20,000 | $17.44 | $348,800 | Direct |
| Sep 2, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 642 | $66.37 | $42,610 | Direct |
| May 6, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 310 | $43.95 | $13,625 | Direct |
| May 5, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 2,181 | $46.65 | $101,744 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 4,250 | - | $0 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Award Performance-based restricted stock units | 8,500 | - | - | Direct |
1-10 of 33 transactions